All Pharma News
Elanco Launches Varenzin™-CA1– the First-of-its-Kind Oral Treatment for Anemia

Elanco Launches Varenzin™-CA1– the First-of-its-Kind Oral Treatment for Anemia
BUSINESSWIRE
07 Sep 2023
Share Share
Elanco Releases 2022 ESG Report, Demonstrating Sustainability Progress

Elanco Releases 2022 ESG Report, Demonstrating Sustainability Progress
BUSINESSWIRE
20 Jul 2023
Share Share
FDA Conditionally Approves First Drug for Nonregenerative Anemia inCats With CKD

FDA Conditionally Approves First Drug for Nonregenerative Anemia inCats With CKD
Alana Hippensteele, Managing Editor PHARMACYTIMES
02 May 2023
Share Share
Elanco Announces FDA Approval of Bexacat (bexagliflozin tablets)

Elanco Announces FDA Approval of Bexacat (bexagliflozin tablets)
BUSINESSWIRE
09 Dec 2022
Share Share
Elanco and Royal DSM Announce Strategic Alliance in U.S. for Bovaer®

Elanco and Royal DSM Announce Strategic Alliance in U.S. for Bovaer®
PRESS RELEASE
27 Apr 2022
Share Share
Elanco Animal Health Incorporated Announces Tender Offer for 2023 Notes

Elanco Animal Health Incorporated Announces Tender Offer for 2023 Notes
BUSINESSWIRE
29 Mar 2022
Share Share
Elanco completes sale of a pair of plants to CDMO TriRx

Elanco completes sale of a pair of plants to CDMO TriRx
Joseph Keenan FIERCEPHARMA
10 Feb 2022
Share Share
Elanco Closes Acquisition of Kindred Biosciences

Elanco Closes Acquisition of Kindred Biosciences
CITIZENTRIBUNE
31 Aug 2021
Share Share
Elanco Animal Health Reports Second Quarter 2021 Results

Elanco Animal Health Reports Second Quarter 2021 Results
BUSINESSWIRE
09 Aug 2021
Share Share
TriRx Completes Acquisition of Elanco Animal Health Facility in Shawnee, Kansas

TriRx Completes Acquisition of Elanco Animal Health Facility in Shawnee, Kansas
PRESS RELEASE
02 Aug 2021
Share Share